English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12340/13424 (92%)
Visitors : 1998532      Online Users : 144
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Community Statistics


    近3年內發表的文件:232(9.42%)
    含全文筆數:2275(92.37%)

    文件下載次數統計
    下載大於0次:2275(100.00%)
    下載大於100次:2275(100.00%)
    檔案下載總次數:1666999(29.37%)

    最後更新時間: 2025-02-26 05:19

    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 351-375 of 2463. (99 Page(s) Totally)
    << < 10 11 12 13 14 15 16 17 18 19 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2022-02-16 Current status of the spectrum and therapeutics of helicobacter pylori-negative mucosa-associated lymphoid tissue lymphoma Cancers. 2022 Feb 16;14(4):Article number 1005.
    2022-02-15 Semaphorin 4C promotes motility and immunosuppressive activity of cancer cells via CRMP3 and PD-L1 American Journal of Cancer Research. 2022 Feb 15;12(2):713-728.
    2022-02-11 Angiogenesis driven by the CEBPD–hsa-miR-429–VEGFA signaling axis promotes urothelial carcinoma progression Cells. 2022 Feb 11;11(4):Article number 638.
    2022-02-10 Prediction model for pancreatic cancer—A population-based study from NHIRD Cancers. 2022 Feb 10;14(4):Article number 882.
    2022-02-02 HDAC6 involves in regulating the lncRNA-microRNA-mRNA network to promote the proliferation of glioblastoma cells Journal of Experimental and Clinical Cancer Research. 2022 Feb 2;41:Article number 47.
    2022-02-01 A prediction model for tumor recurrence in stage II–III colorectal cancer patients: From a machine learning model to genomic profiling Biomedicines. 2022 Feb 1;10(2):Article number 340.
    2022-02-01 Principle-based approach for the de-identification of code-mixed electronic health records IEEE Access. 2022 Feb;10:22875-22885.
    2022-02-01 A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1 Journal of Clinical Oncology. 2022 Feb 01;40(4, Suppl.):378.
    2022-02-01 A prospective phase II study of biweekly S-1, leucovorin and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma Journal of Clinical Oncology. 2022 Feb 01;40(4, Suppl.):550.
    2022-02 Comparison of effectiveness and safety between ticagrelor and clopidogrel in patients with acute coronary syndrome and on dialysis in Taiwan British Journal of Clinical Pharmacology. 2022 Jan;88(1):145-154.
    2022-02 Clinical outcomes of Taiwanese patients with resected oral cavity squamous cell carcinoma who underwent Reconstruction with free versus local flaps Annals of Surgical Oncology. 2022 Feb;29(2):1130-1140.
    2022-02 Incidence and survival variations of upper tract urothelial cancer in Taiwan (2001-2010) International Journal of Urology. 2022 Feb;29(2):121-127.
    2022-02 Fracture risks in patients with atopic dermatitis: A nationwide matched cohort study—reply Annals of Allergy, Asthma and Immunology. 2022 Feb;128(2):Article number 231.
    2022-02 Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): A randomised, multicentre, double-blind, placebo-controlled, phase 3 trial Lancet Oncology. 2022 Feb;23(2):234-247.
    2022-02 A portable controllable compressive stress device to monitor human breast cancer cell protrusions at single-cell resolution Frontiers in Bioengineering and Biotechnology. 2022 Feb;10:Article number 852318.
    2022-02 Phase 1 study of nanoliposomal irinotecan in combination with trifluridine/tipiracil in refractory solid tumors Journal of Clinical Oncology. 2022 Feb;40(4, Suppl.):660.
    2022-02 What can the anti-apoptotic molecule, BIRC5/Survivin, do in the autophagic world? Cancer Science. 2022 Feb;113(S1):41.
    2022-01-28 Investigating the effectiveness of adjuvant therapy for patients with hormone receptor-positive ductal carcinoma in situ PLoS ONE. 2022 Jan 28;17(1):Article number e0262934.
    2022-01-11 Mortality and suicide related to major depressive disorder before and after type 2 diabetes mellitus Journal of Clinical Psychiatry. 2022 Jan 11;83(1):Article number 20m13692.
    2022-01-11 Extracellular HSP90alpha induces MyD88-IRAK complex-associated IKKalpha/Beta−NF-KappaB/IRF3 and JAK2/TYK2−STAT-3 signaling in macrophages for tumor-promoting M2-polarization Cells. 2022 Jan 11;11(2):Article number 229.
    2022-01-06 High level of aristolochic acid detected with a unique genomic landscape predicts early UTUC onset after renal transplantation in Taiwan Frontiers in Oncology. 2022 Jan 06;11:Article number 828314.
    2022-01-05 Heterodimeric vascular endothelial growth factor and use thereof EP3384029/2022-01-05
    2022-01 Comparing survival and subsequent treatment of first-line tyrosine kinase inhibitors in patients of advanced lung adenocarcinoma with epidermal growth factor receptor mutation Journal of the Formosan Medical Association. 2022 Jan;121(1 Pt 1):170-180.
    2022-01 The "Dark Side" of autophagy on the maintenance of genome stability: Does it really exist during excessive activation? Journal of Cellular Physiology. 2022 Jan;237(1):178-188.
    2022-01 Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: Post hoc subanalysis from the ATTRACTION-2 study Gastric Cancer. 2022 Jan;25(1):207-217.

    Showing items 351-375 of 2463. (99 Page(s) Totally)
    << < 10 11 12 13 14 15 16 17 18 19 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback